Recommendations for prophylaxis against pneumocystis carinii pneumonia for persons infected with human

Journal of Acquired Immune Deficiency Syndromes

Volumn 6, Issue 1, 1993, Pages 46-55

  Virus, Immunodeficiency ^a   Masur, Henry ^a   Feinberg, Judith ^a   Bozzette, Samuel A ^a   De Gruttola, Victor ^a   Edlin, Brian ^a   Eisinger, Robert ^a   El Sadr, Wafaa ^a   Ellenberg, Susan ^a   Feigal, David ^a   Frame, Peter ^a   Goldberger, Mark ^a   Hafner, Richard ^a   Hardy, W David ^a   Harrington, Mark ^a   Hughes, Walter ^a   Kerkering, Thomas ^a   Kovacs, Joseph ^a   Leoung, Gifford ^a   Montaner, Julio ^a   Muñoz, Alvaro ^a   Phair, John ^a   Sattler, Fred ^a   Spector, Stephen ^a   Allen, James R ^a   Carr, Andrew ^a   Chaisson, Richard ^a   Freedberg, Ken ^a   McKay, Jean ^a   Polis, Michael ^a   more..

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; ATOVAQUONE; CD4 ANTIGEN; CLINDAMYCIN; COTRIMOXAZOLE; DAPSONE; FANSIDAR; FOLINIC ACID; MALOPRIM; PENTAMIDINE; PRIMAQUINE; TRIMETHOPRIM;

AMINOTRANSFERASE BLOOD LEVEL; BRONCHOSPASM; COST; COUGHING; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG MIXTURE; FEVER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INHALATIONAL DRUG ADMINISTRATION; MORBIDITY; MORTALITY; NAUSEA; NOTE; ORAL DRUG ADMINISTRATION; PATIENT MONITORING; PNEUMOCYSTIS PNEUMONIA; PROPHYLAXIS; PRURITUS; PUBLIC HEALTH SERVICE; RASH; RISK ASSESSMENT; THRUSH; TOXICITY; VOMITING;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; CLINICAL TRIALS; HIV INFECTIONS; HUMAN; PENTAMIDINE; PNEUMONIA, PNEUMOCYSTIS CARINII; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

HUMAN IMMUNODEFICIENCY VIRUS; PNEUMOCYSTIS CARINII;

EID: 0027392656     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Centers for Disease Control. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus. MMWR 1989; 38(S-5):1-9.
2. Sattler FR, Cowan R, Nielsen DM, Ruskin J. Trimethoprim-sulfamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective, noncrossover study. Ann Intern Med 1988; 109:280-7.
3. Bozzette SA, Sattler FR, Chiu J, et al. A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency. N Engl J Med 1990; 323:1451-7.
4. Consensus statement on the use of corticosteroids as adjunctive therapy for pneumocystis pneumonia in the acquired immunodeficiency syndrome. N Engl J Med 1990; 323:1500-4.
5. Masur H, Ognibene FP, Yarchoan R, et al. CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection. Ann Intern Med 1989; 111:223-31.
6. Phair J, Muñoz A, Detels R, et al. The risk of Pneumocystis carinii pneumonia among me infected with human immunodeficiency virus type 1. N Engl J Med 1990; 322:161-5.
7. National Institutes of Health. State of the art conference on azidothymidine therapy of early HIV infection. Am J Med 1990; 89:335-44.
8. Centers for Disease Control. Revised classification system for HIV infection and expanded AIDS surveillance case definition for adolescents and adults. MMWR 1992 (in press).
9. Phair J, Muñoz A, Saah A, et al. Response to letter to the editor. N Engl J Med 1990; 322:1608.
10. Fischi MA, Parker CB, Pettinelli C, et al. A randomized controlled trial of reduced daily dose of zidovudine in patients with the acquired immunodeficiency syndrome. N Engl J Med 1990; 323:1010-25.
11. Hughes WT, Kuhn S, Chaudhary S, et al. Successful chemoprophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med 1977; 297:1419-26.
12. Fischi MA, Dickinson GM, La Voie L. Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS. JAMA 1988; 259:1185-9.
13. Wormser GP, Horowitz HW, Duncanson FP, et al. Lowdose intermittent trimethoprim-sulfamethoxazole for prevention of Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. Arch Intern Med 1991; 151:688-92.
14. Ruskin J, LaRiviere M. Low-dose co-trimoxazole for prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus disease. Lancet 1991; 337:468-71.
15. Northfelt DW, Clement MJ, Safrin S. Extrapulmonary pneumocystosis: clinical features in human immunodeficiency virus infection. Medicine (Baltimore) 1990; 69:392-8.
16. Jules-Elysee K, Stover D, Zaman M, et al. Aerosolized pentamidine: effect on the diagnosis and presentation of Pneumocystis carinii pneumonia. Ann Intern Med 1990; 112:750-7.
17. Levine SJ, Masur H, Gill VJ, et al. The effects of aerosolized pentamidine prophylaxis on the diagnosis of Pneumocystis carinii pneumonia by induced sputum examination in patients infected with the human immunodeficiency virus. Ann Rev Respir Dis 1991; 144:760-4.
18. Hirschl B, Lazzarin A, Chopard P, et al. A controlled study of inhaled pentamidine for primary prevention of Pneumocystis carinii pneumonia. N Engl J Med 1991; 324:1079-83.
19. Montaner JSG, Lawson LM, Gervais A, et al. Aerosol pentamidine for secondary prophylaxis of AIDS-related Pneumocystis carinii pneumonia. Ann Intern Med 1991; 114:948-53.
20. Murphy R, Lavelle J, Allan J, et al. Aerosol pentamidine prophylaxis following Pneumocystis carinii pneumonia in AIDS patients. Am J Med 1991; 90:418-26.
21. Leoung GS, Feigal DW Jr, Montgomery AB, et al. Aerosolized pentamidine for prophylaxis against Pneumocystis carinii pneumonia-The San Francisco Community Prophylaxis Trial. N Engl J Med 1990; 323:769-75.
22. Girard PM, Gaudebout C, Lottin P, et al. Prevention of Pneumocystis carinii pneumonia relapse by pentamidine aerosol in zidovudine-treated AIDS patients. Lancet 1989; 1:1348-53.
23. Centers for Disease Control. Mycobacterium tuberculosis transmission in a health clinic-Florida, 1988. MMWR 1989; 38(15):256-8, 263-4.
24. Centers for Disease Control. Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons-Florida and New York, 1988-1991. MMWR 1991; 40(34):585-91.
25. Nardell EA. Dodging droplet nuclei: reducing the probability of nosocomial tuberculosis transmission in the AIDS era. Am Rev Respir Dis 1990; 142:501-5.
26. Centers for Disease Control. Guidelines for preventing the transmission of tuberculosis in health care settings with special focus on HIV-related issues. MMWR 1991; 39(RR-17):1-29.
27. Hughes WT, Kennedy W, Dugdale M, et al. Prevention of Pneumocystis carinii pneumonitis in AIDS patients with weekly dapsone. Lancet 1990; 336:1066.
28. Kemper CA, Tucker RM, Lang OS, et al. Low-dose dapsone prophylaxis of Pneumocystis carinii pneumonia in AIDS and AIDS-related complex. AIDS 1990; 4:1145-8.
29. Lavelle J, Falloon J, Morgan A, et al. Weekly dapsone and dapsone/pyrimethamine for pneumocystis pneumonia prophylaxis [Abstract no. W.B. 2207]. In: Program and abstract of the VII International Conference on AIDS, Florence, 1991.
30. Hardy WD, Wolfe PR, Gottlieb MS, Knight S, Mitsuyasu R, Young LS. Long-term follow-up of fansidar prophylaxis for Pneumocystis carinii pneumonia in patients with AIDS [Abstract) no. TP. 232]. In: Program and abstracts of the Third International Conference on AIDS (Washington, DC). New York: Elsevier, 1987.
31. Quieffin J, Hunter J, Schecter MT, et al. Aerosol pentamidine-induced bronchoconstriction-predictive factors and preventive therapy. Chest 1991; 100:624-7.
32. Smith RM, Iwamoto GK, Richerson HB, Flaherty JP. Trimethoprim-sulfamethoxzole desensitization in the acquired immunodeficiency syndrome. Ann Intern Med 1987; 106:335.
33. Centers for Disease Control. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with human immunodeficiency virus. MMWR 1991; 40:RR-2.
34. Connor E, Bagarazzi M, McSherry G, et al. Clinical and laboratory correlates of Pneumocystis carinii pneumonia in children infected with HIV. JAMA 1991; 265:1693-7.
35. Kovacs A, Frederick T, Church J, Eller A, Oxtoby M, Mascola L. CD4 T-lymphocyte counts and Pneumocystis carinii pneumonia in pediatric HIV infection. JAMA 1991; 265:1698-703.
36. Carr A, Tindall B, Brew BJ, et al. Low dose trimethoprimsulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS. Ann Intern Med 1992; 117:106-11.